Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Operating Grant

University of Guelph

$100,000.00

Endocannabinoid regulation of nausea in the visceral insular cortex: Assessment by conditioned gaping in rats

EF 2014-15

Résumé
Nausea is a distressing condition that occurs commonly and is very hard to treat. Currently available treatments for nausea and vomiting more effectively control vomiting than nausea. Overall, nausea is currently reported as the most distressing side effect of chemotherapy, and one that often leads patients to discontinue treatment. Nausea is reduced by the active ingredient in marihuana, delta-9-Tetrahydrocannabinol (THC), by its action on cannabinoid 1 (CB1) receptors. The CB1 receptors are naturally activated by chemicals produced in the brain, called endocannabinoids. The action of endocannabinoids, however, is very short, because enzymes break them down rapidly. Drugs which inhibit these degrading enzymes dramatically prolong the action of the endocannabinoids and also suppress nausea in rats. The area of the cerebral cortex that regulates nausea is the visceral insular cortex, a region that receives neural input from the gut. Serotonin in this region triggers nausea and drugs that act on CB1 receptors in this region reduce nausea. The experiments proposed here, will evaluate the potential of endocannabinoid enzyme inhibitors, which prolong the availability of natural endocannabinoids, when directly infused into the visceral insular cortex to reduce nausea in a rat model of nausea. The primary effect of activating CB1 receptors is to reduce the release of neurotransmitters, including serotonin. We will test the hypothesis that the sensation of nausea is triggered by serotonin release within the visceral insular cortex, and the anti-nausea effect of endocannabinoids is the result of "turning off" the release of serotonin in this region. The results of these experiments will provide a better understanding of the neural regulation of nausea, and will lead to new treatments of this difficult to control condition.
Programme
Operating Grant
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
313959
Name
Parker Linda A
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Behavioural Sciences - A: Neurobiological Basis of Behavioural Processes
Projecttitle
Endocannabinoid regulation of nausea in the visceral insular cortex: Assessment by conditioned gaping in rats
Programtype2
Operating Grants
Orgnameinp2
University of Guelph
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Operating Grant
Keyworddelim
Endocannabinoids; Gaping Reactions; Nausea; Serotonin; Taste Reactivity; Visceral Insular Cortex
Abstract
Nausea is a distressing condition that occurs commonly and is very hard to treat. Currently available treatments for nausea and vomiting more effectively control vomiting than nausea. Overall, nausea is currently reported as the most distressing side effect of chemotherapy, and one that often leads patients to discontinue treatment. Nausea is reduced by the active ingredient in marihuana, delta-9-Tetrahydrocannabinol (THC), by its action on cannabinoid 1 (CB1) receptors. The CB1 receptors are naturally activated by chemicals produced in the brain, called endocannabinoids. The action of endocannabinoids, however, is very short, because enzymes break them down rapidly. Drugs which inhibit these degrading enzymes dramatically prolong the action of the endocannabinoids and also suppress nausea in rats. The area of the cerebral cortex that regulates nausea is the visceral insular cortex, a region that receives neural input from the gut. Serotonin in this region triggers nausea and drugs that act on CB1 receptors in this region reduce nausea. The experiments proposed here, will evaluate the potential of endocannabinoid enzyme inhibitors, which prolong the availability of natural endocannabinoids, when directly infused into the visceral insular cortex to reduce nausea in a rat model of nausea. The primary effect of activating CB1 receptors is to reduce the release of neurotransmitters, including serotonin. We will test the hypothesis that the sensation of nausea is triggered by serotonin release within the visceral insular cortex, and the anti-nausea effect of endocannabinoids is the result of "turning off" the release of serotonin in this region. The results of these experiments will provide a better understanding of the neural regulation of nausea, and will lead to new treatments of this difficult to control condition.
Competitiondate
201405
Approvedterm2
1 yr 0 mth
Pinamesdelim
Parker, Linda A
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~